Teehan Emily, Boden Allison L, Jones Agnes, Henry Jensen, Demetracopoulos Constantine
Foot & Ankle Department, Hospital for Special Surgery, New York, NY, USA.
Foot & Ankle Orthopedics, University of Louisville, Louisville, KY, USA.
Foot Ankle Int. 2025 Aug;46(8):845-854. doi: 10.1177/10711007251341316. Epub 2025 Jun 26.
Hindfoot (subtalar, talonavicular, and/or calcaneocuboid) fusion is commonly used to treat arthritis and/or deformity. Some patients undergoing total ankle replacement (TAR) have a history of hindfoot fusion or undergo it concomitantly. This study aims to evaluate Patient-Reported Outcomes Measurement Information System (PROMIS)-based clinical outcomes, revision rates, and radiographic findings of primary TAR with ipsilateral hindfoot fusion at a minimum 2-year follow-up from primary TAR. We hypothesized that TAR patients with ipsilateral hindfoot fusion would have worse patient-reported outcomes and clinical outcomes than TAR-only patients.
A retrospective review of 400 primary TAR patients with or without prior/concomitant ipsilateral hindfoot fusion was conducted. PROMIS domains, radiographs, complications, and revisions were analyzed. Multivariate linear regression models were used to evaluate the associations between hindfoot fusion and 2-year postoperative PROMIS scores. We compared proportions meeting minimal clinically important difference (MCID) and patient-acceptable symptom state (PASS) thresholds.
Of 400 ankles, 49 (12.3%) had ipsilateral hindfoot fusion. On multivariate analysis, hindfoot fusion was associated with worse 2-year PROMIS scores in most domains, including Physical Function, Pain Interference, and Global Mental Health. However, rates of achieving MCID and PASS were largely similar between groups. At 2 years, hindfoot fusion patients were equally likely to achieve MCID in Physical Function, Pain Interference, and Depression, and to meet PASS thresholds for Pain Interference, Pain Intensity, and Physical Function. They were significantly less likely to achieve MCID for Pain Intensity ( = .012) and PASS for Global Mental Health ( = .015) and Depression ( = .024). Revision rate was higher in the hindfoot fusion group (10.2% vs. 2.6%, = .038).
Although patients undergoing TAR with ipsilateral hindfoot fusion report lower absolute PROMIS scores in several domains, they appear equally likely to perceive meaningful clinical improvement and reach acceptable postoperative states in pain and function. These patients may still experience more persistent mental health burden and slightly less improvement in pain intensity.
后足(距下、距舟和/或跟骰)融合术常用于治疗关节炎和/或畸形。一些接受全踝关节置换术(TAR)的患者有后足融合病史或同时进行后足融合术。本研究旨在评估基于患者报告结果测量信息系统(PROMIS)的临床结局、翻修率以及初次TAR并同侧后足融合至少2年随访后的影像学表现。我们假设,与单纯TAR患者相比,同侧后足融合的TAR患者的患者报告结局和临床结局会更差。
对400例有或无既往/同时存在同侧后足融合的初次TAR患者进行回顾性研究。分析PROMIS领域、X线片、并发症和翻修情况。采用多变量线性回归模型评估后足融合与术后2年PROMIS评分之间的关联。我们比较了达到最小临床重要差异(MCID)和患者可接受症状状态(PASS)阈值的比例。
400例踝关节中,49例(12.3%)有同侧后足融合。多变量分析显示,后足融合在大多数领域与术后2年较差的PROMIS评分相关,包括身体功能、疼痛干扰和总体心理健康。然而,两组达到MCID和PASS的比例基本相似。术后2年,后足融合患者在身体功能、疼痛干扰和抑郁方面达到MCID的可能性相同,在疼痛干扰、疼痛强度和身体功能方面达到PASS阈值的可能性相同。他们在疼痛强度方面达到MCID的可能性显著降低(P = 0.012),在总体心理健康方面达到PASS的可能性显著降低(P = 0.015),在抑郁方面达到PASS的可能性显著降低(P = 0.024)。后足融合组的翻修率更高(10.2%对2.6%,P = 0.038)。
虽然接受同侧后足融合TAR的患者在几个领域报告的PROMIS绝对评分较低,但他们在疼痛和功能方面获得有意义的临床改善并达到可接受的术后状态的可能性似乎相同。这些患者可能仍会经历更持续的心理健康负担,疼痛强度的改善也略少。